Standard Biotools (LAB) Divestments (2026)
Standard Biotools (LAB) posted quarterly Divestments of $363.2 million for Q1 2026.
Standard Biotools (LAB) Divestments (2026) Analysis & Trends
Standard Biotools (LAB) has reported Divestments for 1 consecutive years, with $363.2 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 153.43 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Standard Biotools | 253.41 Mn | -223.31 Mn | 10.54 Mn | 24.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.99 Mn |
| Mar 31, 2026 | 363.22 Mn |